volibris
glaxosmithkline (ireland) limited - ambrisentan - háþrýstingur, lungnabólga - háþiýstingslækkandi - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - Æxlishemjandi lyf - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
methergin stungulyf, lausn 0,2 mg/ml
essential pharma limited - methylergometrinum maleat - stungulyf, lausn - 0,2 mg/ml
escitalopram bluefish filmuhúðuð tafla 5 mg
bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 5 mg
escitalopram bluefish filmuhúðuð tafla 10 mg
bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 10 mg
mirtazapin bluefish munndreifitafla 15 mg
bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 15 mg
escitalopram bluefish filmuhúðuð tafla 15 mg
bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 15 mg
mirtazapin bluefish munndreifitafla 30 mg
bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 30 mg
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
ambrisentan mylan
mylan s.a.s - ambrisentan - háþrýstingur, lungnabólga - háþiýstingslækkandi - ambrisentan mylan er ætlað fyrir meðferð lungum slagæð háan blóðþrýsting (pah) í fullorðinn sjúklingum sem hagnýtur bekknum (ÍÞrÓtta) ii að iii, þar á meðal að nota í samsetning meðferð. verkun hefur verið sýnt fram í sjálfvakin pah (ipah) og í pah tengslum við tengdum vef sjúkdómur. ambrisentan mylan er ætlað fyrir meðferð lungum slagæð háan blóðþrýsting (pah) í fullorðinn sjúklingum sem hagnýtur bekknum (ÍÞrÓtta) ii að iii, þar á meðal að nota í samsetning meðferð. verkun hefur verið sýnt fram í sjálfvakin pah (ipah) og í pah tengslum við tengdum vef sjúkdómur.